{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:14:53Z","timestamp":1783401293755,"version":"3.54.6"},"reference-count":27,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Cancer-associated thrombosis is a major cause of morbidity and mortality in oncology patients. Routinely available hematological parameters, including platelet count (PLT), mean platelet volume (MPV), platelet distribution width (PDW), and neutrophil-to-lymphocyte ratio (NLR), may reflect thrombo-inflammatory alterations accompanying thrombotic events in malignancy. Methods: This retrospective exploratory study included 93 patients with solid malignancies who developed radiologically confirmed thrombotic events between 2006 and 2018. Clinical and laboratory data were retrospectively reviewed. Hematological parameters obtained within seven days before and after thrombotic events were compared using appropriate parametric and non-parametric statistical methods. Results: Thrombotic events were most frequently observed in patients with lung, colorectal, breast, and gastric cancers. Gastrointestinal malignancies accounted for 47.3% of cases. Venous thrombotic events represented the majority of cases (63.4%), whereas arterial thrombosis was observed in a smaller subset of patients (10.7%). Pulmonary embolism was identified in 23.7% of patients. Central venous catheter use was significantly associated with subclavian\/femoral vein thrombosis (p &lt; 0.001). PLT significantly decreased following thrombotic events (329.3 \u00d7 103\/\u00b5L vs. 260.8 \u00d7 103\/\u00b5L, p &lt; 0.001), whereas MPV increased modestly (9.23 \u00b1 1.57 fL vs. 9.40 \u00b1 1.45 fL, p &lt; 0.001). PDW significantly decreased (14.37 \u00b1 2.78 vs. 13.63 \u00b1 3.24, p = 0.011). NLR increased numerically (3.33 \u00b1 2.32 vs. 4.26 \u00b1 4.74) but did not reach statistical significance (p = 0.089). An inverse correlation was observed between PLT and MPV (r = \u22120.268, p = 0.009). Conclusions: Routinely available hematological parameters, including PLT, MPV, PDW, and NLR, demonstrated measurable alterations in cancer patients with thrombotic events and may reflect thrombo-inflammatory processes associated with malignancy. However, because of the retrospective design, heterogeneous study population, and absence of a non-thrombotic control group, these findings should be considered exploratory and hypothesis-generating rather than evidence of predictive biomarkers. Larger prospective controlled studies are required to clarify their clinical significance.<\/jats:p>","DOI":"10.3390\/jcm15134998","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:45:20Z","timestamp":1782722720000},"page":"4998","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hematological Changes Associated with Thrombotic Events in Cancer Patients: A Retrospective Exploratory Study"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4070-3697","authenticated-orcid":false,"given":"Yavuz","family":"Kat\u0131rc\u0131lar","sequence":"first","affiliation":[{"name":"Hematology Department, Kayseri City Hospital, Kayseri 38080, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6875-4656","authenticated-orcid":false,"given":"\u0130rfan","family":"Bu\u011fday","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Kayseri City Hospital, Kayseri 38080, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hacer","family":"Demir","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Afyonkarahisar Health Sciences University, Afyon 03030, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mevl\u00fcde","family":"\u0130nan\u00e7","sequence":"additional","affiliation":[{"name":"Medical Oncology Department, Erciyes University Medical School, Kayseri 38039, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"ref_1","first-page":"4259","article-title":"Cancer and coagulation","volume":"113","author":"Khorana","year":"2009","journal-title":"Blood"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO Clinical Practice Guideline Update","volume":"38","author":"Key","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1200\/JCO.2009.22.8197","article-title":"Venous thromboembolism in the hematologic malignancies","volume":"27","author":"Falanga","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-022-00336-y","article-title":"Cancer-associated venous thromboembolism","volume":"8","author":"Khorana","year":"2022","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1200\/JCO.2009.22.3271","article-title":"Assessing risk of venous thromboembolism in the patient with cancer","volume":"27","author":"Khorana","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.critrevonc.2007.01.001","article-title":"Cancer-associated thrombosis","volume":"62","author":"Zwicker","year":"2007","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2017-03-743211","article-title":"Cancer-associated pathways and biomarkers of venous thrombosis","volume":"130","author":"Hisada","year":"2017","journal-title":"Blood"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.thromres.2018.01.017","article-title":"Hemostatic biomarkers in cancer progression","volume":"164","author":"Falanga","year":"2018","journal-title":"Thromb. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/ATVBAHA.111.242859","article-title":"Neutrophil extracellular trap (NET) impact on deep vein thrombosis","volume":"32","author":"Fuchs","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1160\/THS10-11-0720","article-title":"Platelets, inflammation and tissue regeneration","volume":"105","author":"Nurden","year":"2011","journal-title":"Thromb. Haemost."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","article-title":"Direct signaling between platelets and cancer cells induces an epithelial\u2013mesenchymal-like transition and promotes metastasis","volume":"20","author":"Labelle","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pharmthera.2015.11.005","article-title":"Involvement of platelets in tumor cell metastasis","volume":"157","author":"Tesfamariam","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/jcp.2004.025387","article-title":"Platelet volume indices in patients with coronary artery disease and acute myocardial infarction: An Indian scenario","volume":"59","author":"Khandekar","year":"2006","journal-title":"J. Clin. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1742-1241.2009.02070.x","article-title":"The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases","volume":"63","author":"Vizioli","year":"2009","journal-title":"Int. J. Clin. Pract."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/138161211795049804","article-title":"Mean platelet volume: A link between thrombosis and inflammation?","volume":"17","author":"Gasparyan","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","article-title":"The systemic inflammation-based neutrophil\u2013lymphocyte ratio: Experience in patients with cancer","volume":"88","author":"Guthrie","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: A systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13058-016-0794-1","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: A systematic review and meta-analysis","volume":"19","author":"Ethier","year":"2017","journal-title":"Breast Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1470-2045(05)70207-2","article-title":"Cancer and venous thromboembolism","volume":"6","author":"Prandoni","year":"2005","journal-title":"Lancet Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrcardio.2015.83","article-title":"Epidemiology of venous thromboembolism","volume":"12","author":"Heit","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1002\/cncr.21496","article-title":"Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study","volume":"104","author":"Khorana","year":"2005","journal-title":"Cancer"},{"key":"ref_22","first-page":"109","article-title":"Venous thromboembolism and cancer: Risks and outcomes","volume":"349","author":"Lee","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/j.1538-7836.2004.00928.x","article-title":"The risk of a venous thrombotic event in lung cancer patients: Higher risk for adenocarcinoma than squamous cell carcinoma","volume":"2","author":"Blom","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"vi85","DOI":"10.1093\/annonc\/mdr392","article-title":"Management of venous thromboembolism in cancer patients: ESMO Clinical Practice Guidelines","volume":"22","author":"Falanga","year":"2011","journal-title":"Ann. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.2147\/CMAR.S245928","article-title":"The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New Prognostic Factors in Hematological Malignancies\u2014A Narrative Review","volume":"12","author":"Stefaniuk","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/bloodadvances.2025018011","article-title":"Toward new therapy end points in polycythemia vera: Targeting clonal and inflammatory pathways","volume":"10","author":"Barbui","year":"2026","journal-title":"Blood Adv."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00277-026-06763-1","article-title":"Neutrophil to lymphocyte ratio at diagnosis predicts venous thrombosis in prefibrotic primary myelofibrosis: Results from a multicenter cooperative study","volume":"105","author":"Cavalca","year":"2026","journal-title":"Ann. Hematol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/13\/4998\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:20:10Z","timestamp":1783398010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/13\/4998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":27,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["jcm15134998"],"URL":"https:\/\/doi.org\/10.3390\/jcm15134998","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]}}}